HOME Press Releases Infectious Disease Diagnostics Market worth $18,156.2 Million by 2019



Infectious Disease Diagnostics Market worth $18,156.2 Million by 2019


The report "Infectious Disease Diagnostics Market by Product (Instruments, Reagents, Services, Software), Application (Hepatitis C, AIDS, Tuberculosis), Technology (PCR, INAAT, DNA Sequencing, Hybridization), End User (Hospital, Laboratories) - Global Forecast to 2019" provides a detailed overview of major drivers, restraints, challenges, opportunities, current market trends and strategies impacting the global market along with estimates and forecast of revenue.

     Download PDF Brochure     Speak to Analyst     Inquiry Before Buying

Browse 97 market data tables and 35 figures spread through 180 pages and in-depth TOC on “Infectious Disease Diagnostics Market by Product (Instruments, Reagents, Services, Software), Application (Hepatitis C, AIDS, Tuberculosis), Technology (PCR, INAAT, DNA Sequencing, Hybridization), End User (Hospital, Laboratories) - Global Forecast to 2019 ”
http://www.marketsandmarkets.com/Market-Reports/infectious-disease-diagnostics-market-116764589.html
Early buyers will receive 10% customization on reports.

The IDD market is poised to reach $18,156.2 million by 2019 from $12,422.8 million in 2014, at a CAGR of 7.9% from 2014 to 2019.

Factors such as high prevalence rate of infectious diseases, increased demand for rapid diagnostic techniques due to slow turnaround time of current techniques, and the increase in government funding are driving market growth. However, rising healthcare costs and a complex regulatory framework are restraining the growth of the global IDD market.

On the basis of products, the IDD market is segmented into instruments and analyzers, consumables (assays and reagents), and software & services. Consumables accounted for the largest share 70% of the global IDD market in 2014.

On the basis of applications, the IDD market is subsegmented into Hepatitis B, Hepatitis C, Acquired Immunodeficiency Syndrome (AIDS), Tuberculosis (TB), Chlamydia Trachomatis and Gonorrhea, Human Papillomavirus (HPV), Methicillin-resistant Staphylococcus aureus (MRSA), and others.

On the basis of technology, the segment is divided into traditional and molecular diagnostics. Traditional methods are categorized into immunodiagnostics, microscopy, and biochemical characterization. The molecular diagnostics segment is further divided into Polymerase Chain Reaction (PCR), INAAT (Isothermal Nucleic Acid Amplification Test), Hybridization, DNA Sequencing & NGS, microarrays, and others (electrophoresis, mass spectrometry, and flow cytometry). Microarrays and INAAT are expected to be the fastest-growing markets in the forecast period. This remarkable growth is attributed to the specificity and increased efficiency of these tests.

On the basis of end-users, the market is segmented into hospital laboratories, reference labs, physician’s office labs, academics, and others (blood banks, local public health laboratories, home health agencies, nursing homes, point-of-care, self-testing). Hospital laboratories formed the major end-users of the IDD market in 2014.

On the basis of region, the IDD market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World (RoW). In 2014, North America accounted for the largest share of the IDD market, followed by Europe. Both markets are estimated to register single-digit growth rates over the next five years. However, Asia-Pacific is expected to register the highest growth rate during the forecast period, owing to the high prevalence of infectious diseases, and huge investment opportunities due to increase in healthcare expenditure. The growth of the IDD market in Asia-Pacific will revolve around China, India, Australia, and New Zealand. Countries in the Middle East will also show growth.

Major players in this market are Roche Diagnostics (Switzerland), bioMérieux SA (Craponne, France), Thermo Fischer Scientific, Inc. (U.S.), Abbott Laboratories (U.S.), Bio-Rad Laboratories (U.S.), and Becton, Dickinson & Company (U.S.).

About MarketsandMarkets

MarketsandMarkets is world’s No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.

M&M’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.

We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.

Contact:
Mr. Rohan

North - Dominion Plaza,
17304,Preston Road,
Suite 800, Dallas, TX 75252
Tel: +1-888-600-6441
Email: sales@marketsandmarkets.com

Connect Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441

Search reports